NF-Related Articles, Abstracts, and Research Highlights

• E-Medicine: Dermatologic Manifestations of Neurologic Disease
  Theresa Conologue, DO, Staff Physician, Department of Dermatology, National Capital Consortium/Walter Reed Army Medical Center
  
  
• Medical Journal Abstracts (Pub Med)
  Enter search criteria (e.g. 'NF1' or 'neurofibromatosis') in the space provided.
  Click "Go."
  
  
• NF-1
  
  Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59
  NF1 patients
  Marge Lammert, Victor-Felix Mautner, and Lan Kluwe
  
  Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in
  Patients with Neurofibromatosis Type 1
  Ruth Lim, Diego Jaramillo, Tina Young Poussaint, Yuchiao Chang and
  Bruce Korf
  
  NF: Brain tumor study reveals why treatment efforts fail in genetic disorder
  From Washington University School of Medicine
  
  Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).
  Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR.
  
  Self-Concept of Children with NF1
  Belinda Barton and Kathryn North
  
  
• NF-2
  
  Audiologic and radiographic response of NF2-Related vestibular schwannoma to erlotinib therapy.
  Plotkin, SR et al.
  
  Conformal Radiation Therapy for Childhood CNS Tumors.
  David G. Kirsch, Nancy J. Tarbell.
  
  Correlation between VEGF expression and MVD in sporadic and NF2-related schwannomas.
  E. Ditomaso et al.
  
  Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based Study
  Baser, ME et al.
  
  Optic Nerve Sheath Meningiomas in Patients With Neurofibromatosis Type 2
  Bosch, MM et al.
  
  Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in only hearing ear. (Abstract)
  Aristegui M, Denia A.
  
  Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. (Abstract)
  Chan AW, et al.
  
  Stereotactic radiosurgery for vestibular schwannomas in patients with
  neurofibromatosis type 2: an analysis of tumor control, complications, and
  hearing preservation rates.
  Mathieu, D et al.